START Research by
Square feet of world-class research facilities
Oncology Drugs Brought To Market
Locations across the United States and Europe
START Research Capabilities
Phase I Clinical Trials
Non Clinical Research
This is where we test cancer drugs in human beings for the first time. With 13,000 square feet of testing facilities, START is a global leader in phase I cancer research
START performs clinical research to find new candidates for potential anti-cancer compounds.
Your START Research Team
The Doctors on the START Research Team are dedicated to developing novel anti-cancer agents. With their expertise and dedication to this science, patients around the world will have new and more effective opportunities to treat their cancers.